Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date14 Sep 2007 |
|
MechanismmAChRs antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date31 Aug 2007 |
|
MechanismErgosterol biosynthesis inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date22 Mar 2007 |
100 Clinical Results associated with Choseido Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Choseido Pharmaceutical Co., Ltd.
100 Deals associated with Choseido Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Choseido Pharmaceutical Co., Ltd.